Close Menu

Lineagen

By partnering with telehealth provider PWNHealth, Lineagen wants to help children on the autism spectrum start treatment faster and qualify for more benefits.

Lineagen hopes to use PWNHealth's consumer-oriented model to expand access to its testing services for developmental delay and autism spectrum disorder.

NEW YORK (GenomeWeb) – Provo, Utah-based Tute Genomics said today that Patients Know Best — a developer of an online medical records system — has selected its cloud-based software for genome analysis and interpretation.

NEW YORK (GenomeWeb) − Genetic testing firm Lineagen this year plans to launch a sequencing-based diagnostic test for autism spectrum disorder (ASD), developmental delay, and other childhood developmental disorders that will complement its existing microarray-based test.

NEW YORK (GenomeWeb) – Tute Genomics announced that it will provide next-generation sequencing analytics for a molecular diagnostic test being developed by Lineagen for developmental delay, autism spectrum disorders, and other disorders of childhood development.

NEW YORK (GenomeWeb News) – Lineagen today announced it completed a Series C financing round that raised $3.5 million.

Companies that sell or are developing microarray-based tests for early stage autism diagnosis will soon face off against a competitor with a next-generation sequencing-based offering.

NEW YORK (GenomeWeb News) – Researchers have uncovered about two dozen novel copy-number variants strongly linked to autism-spectrum disorders, while also confirming the association of a furth

Lineagen has updated its chromosomal microarray testing service to include new variants associated with autism spectrum disorders.

Researchers who set out to compare the ability of SNP and comparative genomic hybridization microarray platforms to detect copy number variation in autusm spectrum disorder managed to identify 16 genes that hadn't been associated with ASD before.

Pages

A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.